123 related articles for article (PubMed ID: 8040415)
1. Plasma levels of 8-methoxypsoralen after topical paint PUVA on nonpalmoplantar psoriatic skin.
Hallman CP; Koo JY; Omohundro C; Lee J
J Am Acad Dermatol; 1994 Aug; 31(2 Pt 1):273-5. PubMed ID: 8040415
[No Abstract] [Full Text] [Related]
2. Plasma levels of 8-methoxypsoralen after topical paint PUVA.
Pham CT; Koo JY
J Am Acad Dermatol; 1993 Mar; 28(3):460-6. PubMed ID: 8445063
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen.
Neild VS; Scott LV
Br J Dermatol; 1982 Feb; 106(2):199-203. PubMed ID: 7059510
[TBL] [Abstract][Full Text] [Related]
4. Time course of activity of topical 8-methoxypsoralen on palmoplantar skin.
Konya J; Diffey BL; Hindson TC
Br J Dermatol; 1992 Dec; 127(6):654-6. PubMed ID: 1476927
[No Abstract] [Full Text] [Related]
5. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
Steinmeyer K; Grundmann-Kollmann M; Podda M; Kaufmann R
Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of 8-methoxypsoralen following oral or bath-water treatment.
Thomas SE; O'Sullivan J; Balac N
Br J Dermatol; 1991 Jul; 125(1):56-8. PubMed ID: 1873204
[TBL] [Abstract][Full Text] [Related]
7. Plasma and skin concentration of 5-methoxypsoralen in psoriatic patients after oral administration.
Zucchi A; Raho E; Marconi B; Nicoli S; Santini M; Allegra F; Colombo P; Bettini R; Santi P
J Invest Dermatol; 2001 Aug; 117(2):379-82. PubMed ID: 11511320
[TBL] [Abstract][Full Text] [Related]
8. Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
Grundmann-Kollmann M; Podda M; Bräutigam L; Hardt-Weinelt K; Ludwig RJ; Geisslinger G; Kaufmann R; Tegeder I
Br J Clin Pharmacol; 2002 Nov; 54(5):535-9. PubMed ID: 12445034
[TBL] [Abstract][Full Text] [Related]
9. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen.
Tegeder I; Bräutigam L; Podda M; Meier S; Kaufmann R; Geisslinger G; Grundmann-Kollmann M
Clin Pharmacol Ther; 2002 Mar; 71(3):153-61. PubMed ID: 11907489
[TBL] [Abstract][Full Text] [Related]
10. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis.
Collins P; Rogers S
Br J Dermatol; 1992 Oct; 127(4):392-5. PubMed ID: 1419760
[TBL] [Abstract][Full Text] [Related]
11. [Psoriasis phototherapy. Antipsoriatic efficacy of 8-methoxypsoralen and tar baths].
Rowe E; Meffert H; Miehe M; Sönnichsen N
Dermatol Monatsschr; 1985; 171(3):180-4. PubMed ID: 3996697
[No Abstract] [Full Text] [Related]
12. [The pharmacokinetic and toxicologic profile of 8-methoxypsoralen. The basis for safe and effective PUVA therapy].
Schmid J; Brickl R; Koss FW
Derm Beruf Umwelt; 1988; 36(6):177-85. PubMed ID: 3069432
[TBL] [Abstract][Full Text] [Related]
13. Topical 8-methoxypsoralen photochemotherapy of psoriasis: a clinical study.
Danno K; Horio T; Ozaki M; Imamura S
Br J Dermatol; 1983 May; 108(5):519-24. PubMed ID: 6342648
[TBL] [Abstract][Full Text] [Related]
14. Serum 8-methoxypsoralen (8-MOP) concentrations after bath water delivery of 8-MOP plus UVA.
David M; Lowe NJ; Halder RM; Borok M
J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):931-2. PubMed ID: 2254480
[No Abstract] [Full Text] [Related]
15. Determination of 8-methoxypsoralen kinetics: a relevant factor in the treatment of psoriasis by psoralen plus ultraviolet A therapy.
Bonnot D; Béani JC; Boitard M; Reymond JL; Bériel H; Amblard P
Photodermatol Photoimmunol Photomed; 1994 Feb; 10(1):33-7. PubMed ID: 8180098
[TBL] [Abstract][Full Text] [Related]
16. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
Sakuntabhai A; Farr PM; Diffey BL
Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
[TBL] [Abstract][Full Text] [Related]
17. Comparison between plasma levels of 8-methoxypsoralen and skin photosensitivity: the interest of pharmacokinetic studies during photochemotherapy of psoriasis.
Beani JC; Sarrazin C; Amblard P; Reymond JL; Beriel H; Boitard M
Dermatologica; 1983; 166(4):169-74. PubMed ID: 6852331
[No Abstract] [Full Text] [Related]
18. [PUVA therapy: decrease of the 8-methoxypsoralen level following local administration].
Meffert H; Metz D
Dermatol Monatsschr; 1980 Aug; 166(8):566-7. PubMed ID: 7461250
[No Abstract] [Full Text] [Related]
19. [Influence of retinoids on the bioavailability of methoxy-8-psoralen].
Beani JC; Bonnot D; Berthod F; Boitard M; Reymond JL; Beriel H; Amblard P
Ann Dermatol Venereol; 1991; 118(4):273-5. PubMed ID: 2069337
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic determination of methoxsalen in plasma after liquid-solid extraction.
Kucová D; Marysková D; Davídková P; Gasparic J
J Chromatogr; 1993 May; 614(2):340-4. PubMed ID: 8314948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
